Medical News |
- Drug-eluting stents ‘safe in large coronary arteries’
- Edoxaban feasible for thromboprophylaxis after knee surgery
- Bihemispheric stimulation may boost chronic stroke recovery
- NB-UVB irradiation achieved long-term psoriasis remission
- Prostate cancer treatment choices based on more than ‘cancer cure’
- Diabetes linked to poor HRQoL in prostate cancer survivors
- Long-term efficacy of anastazole demonstrated in breast cancer patients
- Prostate cancer treatment choices based on more than ‘cancer cure’
- Diabetes linked to poor HRQoL in prostate cancer survivors
- Fluvastatin’s long-term lipid-lowering effects confirmed in elderly Japanese
- Midlife cholesterol levels not associated with Alzheimer’s risk
- CRP adds little to risk assessment
- CAD, nephropathy linked to non-cleaved osteopontin levels in diabetics
- Kombiglyze XR tablet receives FDA approval for Type 2 diabetes
- Denervation effective for treating resistant hypertension
- CRP adds little to risk assessment
- Drug-eluting stents ‘safe in large coronary arteries’
- Acetylcysteine ineffective for prevention of contrast-induced nephropathy
- Long-term efficacy of anastazole demonstrated in breast cancer patients
| Drug-eluting stents ‘safe in large coronary arteries’ Posted: 18 Nov 2010 04:00 PM PST Drug-eluting stents are no more likely to cause cardiac death or nonfatal myocardial infarction than are bare-metal stents in large coronary arteries, say Swiss scientists who found no intergenerational differences between stents. |
| Edoxaban feasible for thromboprophylaxis after knee surgery Posted: 18 Nov 2010 04:00 PM PST The oral factor Xa inhibitor edoxaban acts in a dose-dependant manner in the prevention of venous thromboembolism in patients undergoing total knee arthroplasty, Japanese research shows. |
| Bihemispheric stimulation may boost chronic stroke recovery Posted: 18 Nov 2010 04:00 PM PST Direct current stimulation of both cerebral hemispheres may translate into improved physical function in patients left with disabilities after a stroke, say US researchers. |
| NB-UVB irradiation achieved long-term psoriasis remission Posted: 18 Nov 2010 04:00 PM PST Narrowband ultraviolet B light irradiation 5 days a week for 4 weeks is an effective treatment option for psoriasis vulgaris, say researchers who found it induced long-term remission. |
| Prostate cancer treatment choices based on more than ‘cancer cure’ Posted: 18 Nov 2010 04:00 PM PST Men with early-stage prostate cancer make treatment decisions based on factors in addition to, and often distinct from, the notion of a "cancer cure," say researchers. |
| Diabetes linked to poor HRQoL in prostate cancer survivors Posted: 18 Nov 2010 04:00 PM PST Study results show that prostate cancer survivors with diabetes report worse long term health-related quality of life than those without the condition, which the researchers believe could have implications for prostate cancer treatment decisions. |
| Long-term efficacy of anastazole demonstrated in breast cancer patients Posted: 18 Nov 2010 04:00 PM PST Results of the Arimidex, Tamoxifen, Alone or in Combination trial at 10 years confirm the long-term superiority of anastrazole over tamoxifen as initial adjuvant therapy for postmenopausal women with hormone-sensitive early breast cancer, researchers report. |
| Prostate cancer treatment choices based on more than ‘cancer cure’ Posted: 18 Nov 2010 04:00 PM PST Men with early-stage prostate cancer make treatment decisions based on factors in addition to, and often distinct from, the notion of a "cancer cure," say researchers. |
| Diabetes linked to poor HRQoL in prostate cancer survivors Posted: 18 Nov 2010 04:00 PM PST Study results show that prostate cancer survivors with diabetes report worse long term health-related quality of life than those without the condition, which the researchers believe could have implications for prostate cancer treatment decisions. |
| Fluvastatin’s long-term lipid-lowering effects confirmed in elderly Japanese Posted: 18 Nov 2010 04:00 PM PST Japanese researchers say that long-term treatment with fluvastatin effectively lowers both low-density lipoprotein cholesterol and total cholesterol levels in hypercholesterolemic patients with or without prior history of cardiac or cerebral events. |
| Midlife cholesterol levels not associated with Alzheimer’s risk Posted: 18 Nov 2010 04:00 PM PST High cholesterol levels in middle-aged women are not associated with an increased risk for Alzheimer's disease, research suggests. |
| CRP adds little to risk assessment Posted: 18 Nov 2010 04:00 PM PST C-reactive protein levels do not provide meaningful information to help guide lipid-lowering therapy for the primary prevention of cardiovascular disease in high-risk patients, conclude the findings of a post hoc analysis of the ASCOT trial. |
| CAD, nephropathy linked to non-cleaved osteopontin levels in diabetics Posted: 18 Nov 2010 04:00 PM PST Elevated plasma levels of osteopontin may be associated with the presence and severity of nephropathy and coronary artery disease in patients with diabetes, according to researchers. |
| Kombiglyze XR tablet receives FDA approval for Type 2 diabetes Posted: 18 Nov 2010 04:00 PM PST Kombiglyze extended release – a once-daily metformin and saxagliptin combination tablet – has been approved by the US Food and Drug Administration for the treatment of Type 2 diabetes. |
| Denervation effective for treating resistant hypertension Posted: 18 Nov 2010 04:00 PM PST Study findings show that catheter-based renal nerve inactivation is effective for significantly reducing blood pressure in patients with hypertension who are resistant to pharmacologic treatment. |
| CRP adds little to risk assessment Posted: 18 Nov 2010 04:00 PM PST C-reactive protein levels do not provide meaningful information to help guide lipid-lowering therapy for the primary prevention of cardiovascular disease in high-risk patients, conclude the findings of a post hoc analysis of the ASCOT trial. |
| Drug-eluting stents ‘safe in large coronary arteries’ Posted: 18 Nov 2010 04:00 PM PST Drug-eluting stents are no more likely to cause cardiac death or nonfatal myocardial infarction than are bare-metal stents in large coronary arteries, say Swiss scientists who found no intergenerational differences between stents. |
| Acetylcysteine ineffective for prevention of contrast-induced nephropathy Posted: 18 Nov 2010 04:00 PM PST Research shows that acetylcysteine treatment does not prevent contrast-induced nephropathy in patients undergoing angiographic procedures. |
| Long-term efficacy of anastazole demonstrated in breast cancer patients Posted: 18 Nov 2010 04:00 PM PST Results of the Arimidex, Tamoxifen, Alone or in Combination trial at 10 years confirm the long-term superiority of anastrazole over tamoxifen as initial adjuvant therapy for postmenopausal women with hormone-sensitive early breast cancer, researchers report. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment